Back

State-of-the-art lecture on atherosclerotic plaque regression

1 September 2025 (13:45 - 14:03)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis: prevention and new regression Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Lina Badimon

Medical School, University of Vic-UCC and IRSI-CC, CIBERCV, Barcelona (Spain)

2 More presentations in this session

Presentation thumbnail
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
Professor Y. Zhou (Beijing, CN)
Abstract Slides
Presentation thumbnail
Effect of 5-lipoxygenase-activating protein inhibiton on coronary atherosclerosis progression in patients with recent acute coronary syndrome: the PASSIVATE randomised clinical trial
Associate Professor M. Chan (Singapore, SG)
Abstract Slides

Access the full session

Session thumbnail
Atherosclerosis: prevention and new regression
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 13:45 CET
You may be interested in
thumbnail
Congress Presentation
Comparing coronary artery plaque regression in patients treated with ezetimibe or PCSK9 inhibitors following acute coronary syndrome: a systematic review and meta-analysis
29 August 2025
thumbnail
Webinar
Recent advances in immune pathways in atherosclerosis
21 April 2021
thumbnail
Congress Presentation
Tracking atherosclerosis progression in clinical practice
12 December 2025
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources